Accessibility Menu
Concord Medical Services logo

Concord Medical Services(NYSE) CCM

Current Price$4.24
Market Cap$11.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2009)-93%
5 Year-84%
1 Year-24%
1 Month-7%
Concord Medical Services last closing stock price
MetricPriceDate
Last closeUSD 4.222026-07-23
Concord Medical Services stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.99%USD 4.352026-07-16
1 month-7.46%USD 4.562026-06-23
3 month+5.5%USD 4.002026-04-24
Year to date+9.33%USD 3.862025-12-31
1 year-24.37%USD 5.582025-07-23
3 year-69.2%USD 13.702023-07-24
5 year-84.49%USD 27.202021-07-23
Since inception-92.8%USD 58.572009-12-11

Concord Medical Services Financials at a Glance

Market Cap

$11.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥585.66M

Net Income (TTM)

-CN¥124.44M

EPS (TTM)

-$2.98

P/E Ratio

-1.42

Dividend

$0.00

Beta (Volatility)

-0.09 (Low)

Price

$4.24

Volume

1,338

Open

$4.24

Previous Close

$4.22

Daily Range

$4.15 - $4.36

52-Week Range

$3.18 - $6.98

Estimated Earnings Date

Sep 25, 2026

CCM News

Did Concord Medical Services Holdings Squander Its Latest Sales Increase?

Seth JaysonJul 22, 2013

Did Concord Medical Services Holdings Squander Its Latest Sales Increase?

Seth JaysonOct 14, 2012

Graying Dragon

Nate WeisshaarJul 28, 2010

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Concord Medical Services

Concord Medical Services Holdings Limited operates a network of radiotherapy and diagnostic imaging centers in China. The company provides advanced cancer treatment services and diagnostic imaging solutions, catering to the growing healthcare needs in the region.

Products and Services
  • Linear accelerators and external beam radiotherapy
  • Proton therapy systems and gamma knife radiosurgery
  • Diagnostic imaging services including MRI and PET-CT
Growth Outlook
  • Increasing demand for cancer treatment services in China
  • Expansion of specialty cancer hospitals to enhance service offerings
  • Investment in advanced medical technologies to improve patient outcomes
Financial Highlights
  • Recent quarterly revenue of 255 million CNY, showing growth potential
  • Trailing twelve months (TTM) gross profit margin of 6.88%
  • Current ratio of 0.48, indicating liquidity challenges
Concord Medical Services Holdings Limited is positioned in a vital sector, addressing the increasing healthcare demands in China. The company's focus on advanced cancer treatment and diagnostic services aligns with the growing prevalence of cancer in the region. Recent financial data indicates a revenue increase, suggesting potential for future growth. However, liquidity challenges highlighted by the current ratio may require attention. The ongoing expansion of specialty cancer hospitals and investment in cutting-edge medical technologies could further enhance the company's market position and service capabilities.
AI Generated • Jul 21, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

610

CEO

Jianyu Yang, PhD, MBA

Website

ir.ccm.cn

Headquarters

Beijing, NY 100020, CN

CCM Financials

Key Financial Metrics (TTM)

Gross Margin

6.88%

Operating Margin

-40.87%

Net Income Margin

-21.25%

Return on Equity

5.73%

Return on Capital

-15.62%

Return on Assets

-1.90%

Earnings Yield

-70.42%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.82M

Volume

1.34K

Avg. Volume

54.85K

Financials (TTM)

Gross Profit

CN¥40.31M

Operating Income

-CN¥239.33M

EBITDA

-CN¥121.18M

Operating Cash Flow

CN¥0.00

Capital Expenditure

CN¥0.00

Free Cash Flow

CN¥0.00

Cash & ST Invst.

CN¥297.79M

Total Debt

CN¥3.63B

Concord Medical Services Performance Analysis

Concord Medical Services annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 70,107,671-6.9%
20232023-12-31CNY 75,850,3648.2%
20242024-12-31CNY 53,350,804-29.7%
20252025-12-31CNY 64,062,92420.1%
Concord Medical Services sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-3121.5%
Q22025-06-30N/A
Q32025-09-3029.6%
Q42025-12-3196.3%
Concord Medical Services annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY -16.65-42.9%
20232023-12-31CNY -9.62-42.2%
20242024-12-31CNY -9.801.9%
20252025-12-31CNY -2.96-69.9%
Concord Medical Services sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-3179.8%
Q22025-06-30N/A
Q32025-09-30-138.7%
Q42025-12-31-97.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CN¥255.10M

+208.9%

Gross Profit

CN¥29.55M

+257.3%

Gross Margin

11.58%

N/A

Market Cap

$11.88MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$19.48K

N/A

Employees

610

N/A

Net Income

-CN¥64.46M

+5.2%

EBITDA

-CN¥20.04M

+85.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CN¥297.79M

-15.1%

Total Debt

CN¥3.63B

-7.5%

Accounts Receivable

CN¥44.05M

-13.9%

Inventory

CN¥45.97M

+37.5%

Long Term Debt

CN¥2.61B

-8.4%

Short Term Debt

CN¥1.02B

-5.1%

Return on Assets

-1.90%

N/A

Return on Invested Capital

-5.21%

N/A

Free Cash Flow

CN¥0.00

N/A

Operating Cash Flow

CN¥0.00

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SYRASyra Health Corp. Class A Common Stock
$0.77+9.90%
CELUCelularity Inc.
$0.76-0.24%
IVFINVO Fertility, Inc.
$1.02-0.49%
WORXSCWorx Corp.
$0.59+7.27%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.15-0.08%
TQQQProShares Trust - ProShares UltraPro Qqq
$64.15-0.03%
TAT&T
$24.04+0.05%
AALAmerican Airlines Group
$14.35+0.06%

Questions About CCM

What is the current price of Concord Medical Services?

Concord Medical Services is trading at $4.24 per share.

What is the 52-week range for Concord Medical Services?

Over the past 52 weeks, Concord Medical Services has traded between $3.18 and $6.98.

How much debt does Concord Medical Services have?

As of the most recent reporting period, Concord Medical Services reported total debt of CN¥520.17M.

How much cash does Concord Medical Services have on hand?

Concord Medical Services reported CN¥42.74M in cash and cash equivalents in its most recent financial results.

What is Concord Medical Services’s dividend yield?

Concord Medical Services does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services